Ani Pharmaceuticals Stock Market Value
| ANIP Stock | USD 62.49 1.03 1.68% |
| Symbol | ANI |
ANI Pharmaceuticals Price To Book Ratio
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of ANI Pharmaceuticals. If investors know ANI will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about ANI Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 13.824 | Earnings Share (1.04) | Revenue Per Share | Quarterly Revenue Growth 0.448 | Return On Assets |
The market value of ANI Pharmaceuticals is measured differently than its book value, which is the value of ANI that is recorded on the company's balance sheet. Investors also form their own opinion of ANI Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is ANI Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because ANI Pharmaceuticals' market value can be influenced by many factors that don't directly affect ANI Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between ANI Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if ANI Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, ANI Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
ANI Pharmaceuticals 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to ANI Pharmaceuticals' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of ANI Pharmaceuticals.
| 12/15/2024 |
| 03/15/2025 |
If you would invest 0.00 in ANI Pharmaceuticals on December 15, 2024 and sell it all today you would earn a total of 0.00 from holding ANI Pharmaceuticals or generate 0.0% return on investment in ANI Pharmaceuticals over 90 days. ANI Pharmaceuticals is related to or competes with Phibro Animal, Prestige Brand, Alkermes Plc, Dr Reddys, Collegium Pharmaceutical, Pacira BioSciences,, and Procaps Group. ANI Pharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets branded and generic prescrip... More
ANI Pharmaceuticals Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure ANI Pharmaceuticals' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess ANI Pharmaceuticals upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 2.1 | |||
| Information Ratio | 0.1059 | |||
| Maximum Drawdown | 18.94 | |||
| Value At Risk | (3.49) | |||
| Potential Upside | 3.04 |
ANI Pharmaceuticals Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for ANI Pharmaceuticals' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as ANI Pharmaceuticals' standard deviation. In reality, there are many statistical measures that can use ANI Pharmaceuticals historical prices to predict the future ANI Pharmaceuticals' volatility.| Risk Adjusted Performance | 0.065 | |||
| Jensen Alpha | 0.2733 | |||
| Total Risk Alpha | 0.4812 | |||
| Sortino Ratio | 0.1288 | |||
| Treynor Ratio | 0.1572 |
ANI Pharmaceuticals Backtested Returns
ANI Pharmaceuticals appears to be very steady, given 3 months investment horizon. ANI Pharmaceuticals secures Sharpe Ratio (or Efficiency) of 0.0788, which signifies that the company had a 0.0788 % return per unit of return volatility over the last 3 months. We have found twenty-nine technical indicators for ANI Pharmaceuticals, which you can use to evaluate the volatility of the firm. Please makes use of ANI Pharmaceuticals' Semi Deviation of 1.93, mean deviation of 1.67, and Risk Adjusted Performance of 0.065 to double-check if our risk estimates are consistent with your expectations. On a scale of 0 to 100, ANI Pharmaceuticals holds a performance score of 6. The firm shows a Beta (market volatility) of 1.03, which signifies a somewhat significant risk relative to the market. ANI Pharmaceuticals returns are very sensitive to returns on the market. As the market goes up or down, ANI Pharmaceuticals is expected to follow. Please check ANI Pharmaceuticals' potential upside, and the relationship between the total risk alpha and kurtosis , to make a quick decision on whether ANI Pharmaceuticals' price patterns will revert.
Auto-correlation | 0.27 |
Poor predictability
ANI Pharmaceuticals has poor predictability. Overlapping area represents the amount of predictability between ANI Pharmaceuticals time series from 15th of December 2024 to 29th of January 2025 and 29th of January 2025 to 15th of March 2025. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of ANI Pharmaceuticals price movement. The serial correlation of 0.27 indicates that nearly 27.0% of current ANI Pharmaceuticals price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.27 | |
| Spearman Rank Test | 0.24 | |
| Residual Average | 0.0 | |
| Price Variance | 3.43 |
ANI Pharmaceuticals lagged returns against current returns
Autocorrelation, which is ANI Pharmaceuticals stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting ANI Pharmaceuticals' stock expected returns. We can calculate the autocorrelation of ANI Pharmaceuticals returns to help us make a trade decision. For example, suppose you find that ANI Pharmaceuticals has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
ANI Pharmaceuticals regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If ANI Pharmaceuticals stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if ANI Pharmaceuticals stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in ANI Pharmaceuticals stock over time.
Current vs Lagged Prices |
| Timeline |
ANI Pharmaceuticals Lagged Returns
When evaluating ANI Pharmaceuticals' market value, investors can use the concept of autocorrelation to see how much of an impact past prices of ANI Pharmaceuticals stock have on its future price. ANI Pharmaceuticals autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, ANI Pharmaceuticals autocorrelation shows the relationship between ANI Pharmaceuticals stock current value and its past values and can show if there is a momentum factor associated with investing in ANI Pharmaceuticals.
Regressed Prices |
| Timeline |
Additional Tools for ANI Stock Analysis
When running ANI Pharmaceuticals' price analysis, check to measure ANI Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy ANI Pharmaceuticals is operating at the current time. Most of ANI Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of ANI Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move ANI Pharmaceuticals' price. Additionally, you may evaluate how the addition of ANI Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.